Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1150 of 5804
-
Pakistan launches largest School-Based obesity prevention trial for kids
Prevention Recruiting nowChildhood obesity is increasing rapidly in Pakistan, but there are no large, high-quality studies testing ways to prevent it in schools. This study aims to find out if a 9-month program involving health education, daily physical activity, parent workshops, and regular feedback vi…
Phase: NA • Sponsor: Central South University • Aim: Prevention
Last updated Jun 27, 2026 13:01 UTC
-
Supercharged poop pills aim to heal radiation gut damage
Disease control OngoingThis is a randomized controlled trial to explore the exploring the non-inferiority of CMTS0515-augmented WMT compared to WMT.
Phase: PHASE1, PHASE2 • Sponsor: The Second Hospital of Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Could biologic drugs offer a better way to treat lupus kidney disease?
Disease control Recruiting now1. Study Design This is a single-center, prospective, randomized, controlled, exploratory clinical trial. The study is designed to evaluate and compare the efficacy and safety of two biologic-based induction regimens against standard of care (SOC) and a triple-combination regimen…
Phase: PHASE2 • Sponsor: Nanjing University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New therapy aims to break the link between childhood trauma and suicide
Symptom relief Recruiting nowThe investigators have developed a novel suicide intervention, Integrated Suicide and Trauma Therapy (ISTT). ISTT combines Brief-Skills for Safer Living (Brief-SfSL)-a promising method to enhance coping skills and reduce suicidality-with a trauma therapy component to alleviate th…
Phase: NA • Sponsor: Unity Health Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Can a common drug reverse Poison-Induced delirium? new study says yes
Symptom relief CompletedThis study aims to evaluate the clinical efficacy and safety of rivastigmine in reversing the full spectrum of anticholinergic delirium including hypoactive delirium which is presented with CNS depression and hyperactive or agitated delirium. The study was conducted on 100 patie…
Phase: PHASE4 • Sponsor: Alexandria University • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New hope for endometriosis pain: hormone pill targets inflammation
Disease control Recruiting nowThe purpose of this study is to better understand how hormone suppression with Relugolix Combination-Therapy (CT) affects pelvic pain, inflammation, and pain sensitivity in women with moderate-to-severe endometriosis associated pelvic pain.
Phase: PHASE3 • Sponsor: University of Michigan • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New hope for Hard-to-Treat ovarian cancer: drug combo enters human testing
Disease control Recruiting nowThe purpose of this study is to learn about the safety and tolerability of Cirtuvivint in combination with Olaparib in platinum resistant ovarian cancer. The study also aims to determine the recommended dose of the combination therapy. If a participant is a good fit for the stud…
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Nurses take the lead: could nurse-led methadone dosing keep more people in treatment?
Disease control Recruiting nowInitiations of methadone treatment for opiode use disorder (OUD) are carried out in France in specialized centers, known as centers for care, support and prevention in addictology (CSAPA) In this way, hospital practitioners initiate the prescription of methadone, which is deliver…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Can a heart scan predict who will get better? new study aims to find out
Knowledge-focused ENROLLING_BY_INVITATIONBackground: Heart failure with reduced ejection fraction (HFrEF) is a heterogeneous condition with variable potential for left ventricular ejection fraction (LVEF) recovery. While LVEF improvement and reverse remodeling predict better outcomes, the determinants that predict left…
Phase: PHASE4 • Sponsor: Gødstrup Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
New drug EDI048 takes on stomach bug in human trial
Disease control Recruiting nowThis study has the purpose to demonstrate prospect of benefit of EDI048 on clinical signs and symptoms of cryptosporidiosis to facilitate trial in target population, pediatric patients. This study aims to investigate the efficacy of a new chemical entity, EDI048, in a controlled…
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New shot aims to tame dangerously high blood fats
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and efficacy of solbinsiran in lowering triglycerides and other lipid measures compared to placebo in participants with severe hypertriglyceridemia. Participants will receive two subcutaneous injections.
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Radiation may control breast cancer when surgery Isn't an option
Disease control Recruiting nowThe purpose of this study is to find out if adding radiation therapy to routine medications for breast cancer helps in reducing and preventing the cancer from getting worse. Patients with a locally advanced breast cancer who cannot, or do not want to, undergo surgery are eligible…
Phase: NA • Sponsor: Alexander Stessin • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New camera eye could catch colon cancer early in IBD patients
Diagnosis Recruiting nowTexture and Colour Enhancement Imaging (TXI) improves texture, brightness, and colour in white-light endoscopy to highlight subtle tissue differences. Now available through the EVIS X1 system, early evidence suggests potential value in IBD. Studies show that TXI may help predict …
Phase: NA • Sponsor: London North West Healthcare NHS Trust • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
Radiation boosts immunotherapy in Hard-to-Treat cancers?
Disease control Recruiting nowThis is a non-randomized two-arm trial, specifically a pilot study in which patients with advanced solid tumor cancer with 3-10 metastatic lesions who are on immunotherapy will receive ablative RT to up to 10 lesions. After study intervention, participants will undergo ctDNA coll…
Phase: PHASE1 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Robotic glove plus zaps may restore hand movement in stroke survivors
Symptom relief Recruiting nowStroke is a clinically delineated syndrome, which is characterised by an acute, focal neurological deficit resulting from vascular injury (infarction or haemorrhage) within the central nervous system. Notably, around 80 percent of stroke survivors experience post-stroke deficits …
Phase: NA • Sponsor: Lahore University of Biological and Applied Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could a diabetes pill slow lung cancer? new trial aims to find out
Disease control Not yet recruitingThe goal of this clinical trial The goal of this clinical trial is to evaluate whether SGLT2 inhibitor drugs can extend overall survival or delay the progression of the tumor in patients with both advanced lung cancer and diabetes. It will also check if these drugs are safe for …
Phase: NA • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Morning vs. afternoon: timing of immunotherapy may impact lung cancer outcomes
Knowledge-focused Recruiting nowThis prospective study aims to investigate whether the time of day when immune checkpoint inhibitors (ICIs) are administered affects the efficacy of neoadjuvant immunotherapy in patients with resectable stage II-III non-small cell lung cancer (NSCLC). Eligible patients will recei…
Phase: PHASE3 • Sponsor: Hunan Province Tumor Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Can a womb-relaxing drug boost IVF success? new trial aims to find out.
Symptom relief Recruiting nowThis study aims to evaluate the efficacy of atosiban in patients with previous pregnancy failure and abnormal uterine contractions during the peri-embryo transfer period in assisted reproductive technology. The main questions it aims to answer are: * Does the use of atosiban in …
Phase: NA • Sponsor: Northwest Women's and Children's Hospital, Xi'an, Shaanxi • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New shot aims to stop peanut allergy emergencies
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety, pharmacokinetics, and effectiveness of MY006, a therapy designed to prevent severe or potentially life-threatening allergic reactions caused by accidental peanut intake. In the first part of the study, adult participants …
Phase: PHASE1 • Sponsor: Mabylon AG • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Immune cell double punch takes on Hard-to-Treat tumors
Disease control Recruiting nowThis is an open-label, single-arm clinical study designed to evaluate the safety and preliminary efficacy of Targeted Activated DC combined with CAR-T therapy in patients with Advanced Solid Cancers.This combination therapy activates dendritic cells (DCs) to precisely target the …
Phase: EARLY_PHASE1 • Sponsor: Hainan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC